ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Lupus nephritis"

  • Abstract Number: 1485 • ACR Convergence 2021

    Glycosphingolipids: Potential Urine Biomarkers of Therapeutic Response in Lupus Nephritis

    Tammy Nowling, Jessalyn Rodgers, Bethany Wolf, Brian Troyer and Jim Oates, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Lupus nephritis (LN) is a chronic, immune complex-mediated glomerulonephritis affecting up to 60% of patients with lupus. Progression of the most aggressive forms of…
  • Abstract Number: 1937 • ACR Convergence 2021

    IL-16 Is Linked to Lupus Nephritis Activity

    Andrea Fava1, Deepak Rao2, Chandra Mohan3, Ting Zhang3, Avi Rosenberg1, Paride Fenaroli4, H. Michael Belmont5, Peter Izmirly6, Robert Clancy7, Jose Monroy-Trujillo1, Derek Fine1, Arnon Arazi8, Celine Berthier9, Anne Davidson10, Judith James11, Betty Diamond12, Nir Hacohen13, David Wofsy14, Soumya Raychaudhuri2, Accelerating Medicines Partership (AMP) RA/SLE Network15, Jill Buyon5, Michelle Petri16 and The Accelerating Medicines Partnership in RA/SLE17, 1Johns Hopkins University, Baltimore, MD, 2Brigham and Women's Hospital, Boston, MA, 3University of Houston, Houston, TX, 4Universita` degli Studi di Parma, Parma, Italy, 5NYU School of Medicine, New York, NY, 6New York University School of Medicine, New York, NY, 7NYU Grossman School of Medicine, New York, NY, 8Feinstein Institutes for Medical Research, Melrose, MA, 9University of Michigan, Ann Arbor, MI, 10Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11Oklahoma Medical Research Foundation, Oklahoma City, OK, 12Northwell Health, Manhasset, NY, 13Broad Institute, Cambridge, MA, 14University of California San Francisco, San Francisco, CA, 15Brigham and Women's Hospital, Everett, MA, 16Johns Hopkins University School of Medicine, Baltimore, MD, 17Multiple Institutions, Multiple

    Background/Purpose: There is a pressing need to identify novel therapeutic targets in lupus nephritis. Multiomic approaches hold great potential for discovery. We integrated urine proteomics…
  • Abstract Number: 0341 • ACR Convergence 2021

    Addition of Narrative Text Abstraction to ICD-Based Abstraction Significantly Improves Identification of Lupus Nephritis in Real-World Data

    Meghan Tierney and Chris Rowe, PicnicHealth, San Francisco, CA

    Background/Purpose: Lupus nephritis (LN) is often underrecognized and difficult to identify retrospectively, presenting challenges for clinicians and researchers hoping to explore this condition using real-world…
  • Abstract Number: 0966 • ACR Convergence 2021

    Integrated Single Cell RNA-Sequencing Analysis of Tissue-Localized T Cells in Cutaneous Lupus and Lupus Nephritis

    Garett Dunlap1, Allison Billi2, Feiyang Ma3, Johann Gudjonsson2, J. Michelle Kahlenberg4 and Deepak Rao5, 1Harvard University, Somerville, MA, 2Department of Dermatology, University of Michigan, Ann Arbor, MI, 3University of California Los Angeles, Los Angelas, CA, 4University of Michigan, Ann Arbor, MI, 5Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Cutaneous lupus erythematosus (CLE) is commonly present in patients with systemic lupus erythematosus (SLE), but can also exist as an isolated manifestation without further…
  • Abstract Number: 1503 • ACR Convergence 2021

    Putting the Pieces on the Board: Mapping SLE Nephritis Biopsies from the Accelerating Medicines Project Using High-Density Immunofluorescence Imaging

    Craig Smuda1, Anna Eichinger2, Robert Clancy2, Jill Buyon3 and Boris Reizis4, 1NYU Grossman School of Medic ine, New York, NY, 2NYU Grossman School of Medicine, New York, NY, 3NYU School of Medicine, New York, NY, 4New York University Grossman School of Medicine, New York, NY

    Background/Purpose: The Accelerating Medicines Project (AMP) has enabled significant increases in understanding of SLE nephritis pathology, providing a profile of dozens of leukocyte subsets within…
  • Abstract Number: 0342 • ACR Convergence 2021

    RAIL Distinguishes Responder and Non-Responder in Pediatric Lupus Nephritis

    Ellen Cody1, Scott Wenderfer2, Qing Ma1, Angela Merritt1, Prasad Devarajan1 and Hermine Brunner1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Baylor College of Medicine, Houston, TX

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a diagnostic and therapeutic challenge, particularly lupus nephritis (LN). We described a composite score, the Renal Activity Index for…
  • Abstract Number: 0973 • ACR Convergence 2021

    Modeling of Clinical Phenotypes in SLE Based on Platelet Transcriptomic Analysis and FCGR2a Biallelic Variants

    MacIntosh Cornwell1, Hanane EL Bannoudi2, Elliot Luttrell-Williams1, Khrystyna Myndzar1, Alexis Engel3, Peter Izmirly4, H. Michael Belmont5, Robert Clancy6, Jeffrey Berger1, Kelly Ruggles1 and Jill Buyon6, 1New York University, New York, NY, 2NYU Langone Health, New York, NY, 3NYU Langone Health, New Yok, NY, 4New York University School of Medicine, New York, NY, 5NYU School of Medicine, New York, NY, 6NYU Grossman School of Medicine, New York, NY

    Background/Purpose: The clinical heterogeneity of SLE with its complex pathogenesis remains challenging as we strive to provide optimal management. The contribution of platelets to endovascular…
  • Abstract Number: 1505 • ACR Convergence 2021

    Inflammatory Dendritic Cell and Th17 Polarization in Mouse Model of Lupus Nephritis

    Latha Prabha Ganesan1, Noushin Saljoughian1, James Turman1, Murugesan Rajaram1, Brad Rovin2, Wael Jarjour1 and Samir Parikh2, 1Ohio State University, Columbus, OH, 2Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: We have recently identified inflammatory dendritic cells (InfDC) in human lupus kidneys. These cells are over expressed in LN patients compared to healthy controls.…
  • Abstract Number: 0350 • ACR Convergence 2021

    EPI-SIGN: Epigenetic SLE Indicators of Glomerular Nephritis

    Ashira Blazer1, Olusola Ayanlowo2, Will Liao3, Dzifa Dey4, Jasmin Divers5, Uyiekpen Ima-Edomwonyin6, Hakeem Olaosebikan7, Cristina Lanata8, Girish Nadkarni9, Jill Buyon1, Peter Izmirly10 and Timothy Niewold11, 1NYU School of Medicine, New York, NY, 2College of Medicine University of Lagos, New York, NY, 3New York Genome Center, New York, NY, 4University of Ghana, Accra, Ghana, 5NYU Langone Hospital - Long Island, Mineola, NY, 6Lagos State University Teaching Hospital, Lagos, Nigeria, 7Lagos University State Teaching Hospital, Lagos, Nigeria, 8University of California San Francisco, Moss Beach, CA, 9Icahn School of Medicine at Mount Sinai, New York, NY, 10New York University School of Medicine, New York, NY, 11Colton Center for Autoimmunity NYU School of Medicine, New York, NY

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is more common and severe in those of African Ancestry (AA) who, relative to Europeans, are twice as likely to…
  • Abstract Number: 1270 • ACR Convergence 2021

    Disease Severity and Healthcare Costs Associated with Chronic Kidney Disease in Patients with Systemic Lupus Erythematosus

    Shirley Huang1, Amy Guisinger2, Carlyne Averell1 and Christopher Bell1, 1GlaxoSmithKline, Research Triangle Park, NC, 2US Value, Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC

    Background/Purpose: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), occurring in approximately 40% of SLE patients (pts) and often resulting in…
  • Abstract Number: 1627 • ACR Convergence 2021

    Long Term Follow-Up of Patients with Childhood-Onset Lupus Nephritis After Transition to Adult Care

    Dahima Cintrón1, Suheiry Márquez1 and Luis Vilá2, 1University of Puerto Rico Medical Sciences Campus, San Juan, PR, 2University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

    Background/Purpose: Approximately 20% of patients with systemic lupus erythematosus (SLE) are diagnosed before 18 years of age. Pediatric patients have a worse disease course when…
  • Abstract Number: 0353 • ACR Convergence 2021

    Soluble Urine ALCAM Reflects Renal Disease Activity in Lupus Nephritis

    Dalena Chu1, Noa Schwartz2, Jeanette Ampudia1, Joel Guthridge3, Judith James3, Jill Buyon4, Stephen Connelly1, Maple Fung5, Cherie Ng1, Chandra Mohan6 and Chaim Putterman7, 1Equillium, Inc., La Jolla, CA, 2Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4NYU School of Medicine, New York, NY, 5Equillium, Inc., San Diego, CA, 6University of Houston, Houston, TX, 7Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Lupus nephritis (LN) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE) patients. While LN pathogenesis has yet to be…
  • Abstract Number: 1271 • ACR Convergence 2021

    Healthcare Resource Utilization and Costs Associated with Systemic Lupus Erythematosus After Diagnosis of End-Stage Kidney Disease: Evidence from Two United States Databases

    Shirley Huang1, Amy Guisinger2 and Christopher Bell1, 1GlaxoSmithKline, Research Triangle Park, NC, 2US Value, Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC

    Background/Purpose: Approximately 40% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN), of whom up to 20% may progress to end-stage kidney disease…
  • Abstract Number: 1736 • ACR Convergence 2021

    Treatment of Lupus Nephritis with Belimumab Is Associated with Reduction in Urinary CD23

    Emma Weeding1, Andrea Fava2, Chandra Mohan3, Daniel Goldman4 and Michelle Petri4, 1Johns Hopkins Hospital, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3University of Houston, Houston, TX, 4Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Urine proteomic approaches have shown promise in identifying dynamic biological pathways in lupus nephritis (LN) which are not captured on renal histopathology or by…
  • Abstract Number: 0356 • ACR Convergence 2021

    The Role of Neutrophils in the Clinical Severity of Lupus Nephritis Patients with Concurrent Skin Disease

    Lais Osmani, Sicong Shan, Zoe Chafouleas, Jason Pettus and Sladjana Skopelja-Gardner, Dartmouth Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: Skin disease affects >80% of lupus patients and has been linked to lupus nephritis (LN) flares. We recently found that skin inflammation caused by…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 19
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies